Highly Effective Naturally Acquired Protection Against COVID-19 Persists for at Least 1 Year: A Meta-Analysis
Author:
- 16 September 2021
- journal article
- letter
- Published by Elsevier in Journal of the American Medical Directors Association
- Vol. 22 (11) , 2263-2265
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- SARS-CoV-2 seropositivity and subsequent infection risk in healthy young adults: a prospective cohort studyThe Lancet Respiratory Medicine, 2021
- The protective effect of SARS-CoV-2 antibodies in Scottish healthcare workersERJ Open Research, 2021
- SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN)The Lancet, 2021
- Prior COVID-19 significantly reduces the risk of subsequent infection, but reinfections are seen after eight monthsJournal of Infection, 2021
- Prior SARS-CoV-2 infection is associated with protection against symptomatic reinfectionJournal of Infection, 2021
- Reinfection Rates Among Patients Who Previously Tested Positive for Coronavirus Disease 2019: A Retrospective Cohort StudyClinical Infectious Diseases, 2021
- Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational studyThe Lancet, 2021
- SARS-CoV-2 Infection Severity Is Linked to Superior Humoral Immunity against the SpikemBio, 2021
- SARS‐CoV‐2 re‐infection risk in AustriaEuropean Journal of Clinical Investigation, 2021
- Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care WorkersNew England Journal of Medicine, 2021